InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,962.40
(
-1.27%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.29
(
1.51%
)
Bitcoin
59,948.51
(
-5.08%
)
Post# of 252334
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Summer2762

Send PM Follow Ignore
Followers 7
Posts 193
Boards Moderated 0
Alias Born 10/26/2011

Summer2762

Re: gfp927z post# 137740

Friday, 02/24/2012 3:17:44 AM

Friday, February 24, 2012 3:17:44 AM

Post# of 252334

The MTD for TH-302 is 575 mg/m2.



That's for monotherapy. With gemcitabine the MTD was established to be 340 mg/m2.

In general, be mindful of PFS data in an open label study (especially if the study allows crossover). I would wait to see a) LA/M ratio to validate 3.6m median for gem arm b) dropout ratios in both arms.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up